Overcoming process development and biologics manufacturing challenges

•Descargar como PPT, PDF•

6 recomendaciones•1,823 vistas

Speakers: Tom Wellner and David Bell from Therapure Biopharma Part of the Drug Development Discussion Group Event Series at MaRS. For more information, please visit: http://www.marsdd.com/Events/Event-Calendar/Drug-Development-Discussion-Group/therapure-05152009.html

Empresariales Tecnología

MaRS | May 15, 2009 Thomas G. Wellner – President & CEO Dr. David N. Bell – VP Drug Development & CSO www.therapurebio.com

of all new products The future of medicine 1 3 /

$51B $87B $25B $89B 2001 Protein therapeutic market 2005 2010 2010 Worldwide mobile technology market

You discovered a protein with blockbuster potential ,[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],You are working hard to develop it ,[object Object],[object Object],[object Object],[object Object],[object Object]

Discovery Development Marketing Manufacturing

Scaling up is not easy ,[object Object],[object Object],[object Object],[object Object],commercial bench ,[object Object],[object Object],[object Object],[object Object]

Therapure Biopharma: Overcoming the manufacturing barrier Complex We know protein purification Long lead times Ready to go now Quality cGMP compliant Expensive Established Meadowpine Facility Regulated We have 8 INDs under our belts

Therapure Biopharma Inc. ,[object Object],[object Object],[object Object],[object Object],[object Object],Committed to the development, manufacture, purification, and packaging of high-quality biological therapeutics

Therapure Biopharma – Key Facts ,[object Object],[object Object],[object Object],[object Object],[object Object]

Modern and Flexible Facility ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Our Business Strategy Cornerstone CDMO Business Unique & Flexible Facility Scientific & Biomanufacturing Expertise Creative Financing ,[object Object],[object Object],[object Object]

Key Milestones ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Key Clients / Global Collaborations ,[object Object],[object Object],[object Object],[object Object],[object Object]

Experienced Sr. Management Team ,[object Object],[object Object],[object Object],[object Object]

Sophisticated Biologic Development & Manufacturing Services

Integrated Full Service Provider ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Fully Integrated Services ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Commercial Product

High Quality Manufacturing Facility Chromatography Analytical Laboratory Vial filling line Buffer farm

Support Beyond Development & Manufacturing

Creative Financing Opportunities ,[object Object],[object Object],[object Object],[object Object]

Más contenido relacionado

Destacado

Generics and Biologics

Dr Kamal Sundar

Pharmaceutical Best Practices: R&D Strategic Partnerships

Thomas Macpherson

BioPharma Data Trends

Thomas Macpherson

Ibc cell therapy clinical development conference (arlington va september 10 ...

Proteus Venture Partners

Production and purification of Viral vectors for gene and cell therapy appli...

Dr. Priyabrata Pattnaik

Gene therapy.. Dr.Padmesh

Dr Padmesh Vadakepat

Destacado (6)

Generics and Biologics

Pharmaceutical Best Practices: R&D Strategic Partnerships

BioPharma Data Trends

Ibc cell therapy clinical development conference (arlington va september 10 ...

Production and purification of Viral vectors for gene and cell therapy appli...

Gene therapy.. Dr.Padmesh

Similar a Overcoming process development and biologics manufacturing challenges

Therapure Bio Contact Presentation Sept 29 08

Thomas Wellner

Anteo Diagnostics Microcap Presentation October 2013

Matt Sanderson

Innovotech Investor Presentation December 1, 2010

Innovotech Inc.

Fine Chem & Bio Products Final

Scott Waterhouse

Piramal Clinical Trial Services

Phil Smith

LMF resume 2015 v11

♦♦♦Lyndon M. Foster MS., Ph.D.

Viropro investor presentation 01_apr11

rvdatar

Investor Presentation Nov

cruwe

Innovotech AGM Presentation April 19 2011

Innovotech Inc.

Founded in 1980, Kemwell provides customized process/product development and manufacturing to biopharmaceutical organizations worldwide. Our facilities are located in Bangalore, India and were built with technical guidance from Boehringer Ingelheim, providing customers with state-of-the-art technology along with the benefit of cost-effective manufacturing. The 15,000 sq. m. facility consist of a cGMP drug substance manufacturing facility with 2x2000L bioreactors and a sterile fill and finish facility for cGMP drug product manufacturing with a floor for process development laboratories to support production of protein therapeutics from mammalian-cell culture or microbial fermentation. For over 30 years, Kemwell supported pharmaceutical companies with their development and manufacturing needs. We developed and manufactured drugs for some of the world’s top pharmaceutical companies including Bayer, GlaxoSmithKline, Merck KGaA, Novartis and Pfizer. In 2017, Kemwell sold its pharmaceutical business to Recipharm AB but continues to leverage its 30-year experience to provide biotech customers with cost-effective solutions.

Kemwell biologics presentation bp April 2018

MithaliRosario

Marketing II: Indu Isaacs

Laurence Patrick Noonan

PCT Presentation Shared October 2016

Cenk Sumen

Synthon, The Value Chain of a specialty pharmaceutical company

Health Valley

MBC Company Profile

Mohamed Abu al khair

Nrc slides

Dr. Mislav Steven Pavelic

Application of Technology Acquisition for Corporate Growth

Nile University

Walter King Resume 2015

Walter King

SILS 2015 - Innovation at GE Healthcare

Sherbrooke Innopole

Apresentação cipan sbe ist_2016_4(post link_in)

Manuel Eduardo Fernandes

2016 Thermo Fisher Scientific Company Overview

Josie Zheng

Similar a Overcoming process development and biologics manufacturing challenges (20)

Therapure Bio Contact Presentation Sept 29 08

Anteo Diagnostics Microcap Presentation October 2013

Innovotech Investor Presentation December 1, 2010

Fine Chem & Bio Products Final

Piramal Clinical Trial Services

LMF resume 2015 v11

Viropro investor presentation 01_apr11

Investor Presentation Nov

Innovotech AGM Presentation April 19 2011

Kemwell biologics presentation bp April 2018

Marketing II: Indu Isaacs

PCT Presentation Shared October 2016

Synthon, The Value Chain of a specialty pharmaceutical company

MBC Company Profile

Nrc slides

Application of Technology Acquisition for Corporate Growth

Walter King Resume 2015

SILS 2015 - Innovation at GE Healthcare

Apresentação cipan sbe ist_2016_4(post link_in)

2016 Thermo Fisher Scientific Company Overview

Más de MaRS Discovery District

In this new age of networked intelligence, collaborative communities are enhancing and even bypassing crumbling institutions. We are innovating the way our financial institutions and governments operate; how we educate our children; how the healthcare, newspaper, and energy industries serve their customers; how we care for our neighbourhoods; and even how we solve global problems. From his latest book, (co-author Anthony D. Williams) Macrowikinomics: New Solutions for a Connected Planet, Don Tapscott presents groundbreaking innovations from every corner of the globe: how businesses, organizations and individuals alike are using mass collaboration to revolutionize not only the way we work, but how we live, learn, create and care for each other.

Don Tapscott's New Solutions for a Connected Planet - MaRS Global Leadership

Overcoming process development and biologics manufacturing challenges

Recomendados

Recomendados

Más contenido relacionado

Destacado

Destacado (6)

Similar a Overcoming process development and biologics manufacturing challenges

Similar a Overcoming process development and biologics manufacturing challenges (20)

Más de MaRS Discovery District

Más de MaRS Discovery District (20)

Último

Último (20)

Overcoming process development and biologics manufacturing challenges